OBJECTIVE: Although age-related confluent white-matter lesion (WML) is an important substrate for cognitive impairment, the mechanisms whereby WML induces cognitive impairment are uncertain. The authors investigated cognitive predictors in patients with confluent WML. METHODS: Among 100 patients with ischaemic stroke with confluent WML on MRI, the authors assessed executive function and global cognition by the Mattis Dementia Rating Scale--Initiation/Perseveration Subscale (MDRS I/P) and Mini-Mental State Examination (MMSE), respectively. All volumetric measures were corrected for intracranial volume. The authors investigated the association between basic demography, vascular risk factors, APOE status, WML volume, infarct measures (volume, number, location), microbleed number, atrophy measures (global, central, regional) and cognitive performance. The authors also performed Pittsburgh Compound B (PIB) imaging among seven cognitive impaired patients with stroke. RESULTS:WML was no longer related to cognitive performance after adding atrophy into regression equations. Multivariate regression models showed that cortical grey matter volume independently accounted for performance on both the MDRS I/P (β=0.241, p=0.045) and MMSE (β=0.243, p=0.032). Models examining frontal subregions revealed that volumes of both left (β=0.424, p<0.001) and right (β=0.219, p=0.045) lateral frontal orbital gyri predicted MDRS I/P, whereas education (β=0.385, p<0.001) and left lateral frontal orbital gyrus (β=0.222, p=0.037) predicted MMSE. Volumes of WML and cognitively relevant brain regions were significantly associated. Seven patients with PIB imaging showed no uptake pattern typical of Alzheimer's disease, suggesting a predominantly vascular aetiology for the cognitive impairment and brain changes in these patients. CONCLUSIONS:Cognitive impairment in patients with confluent WML is mediated by global and frontal cortical atrophy.
RCT Entities:
OBJECTIVE: Although age-related confluent white-matter lesion (WML) is an important substrate for cognitive impairment, the mechanisms whereby WML induces cognitive impairment are uncertain. The authors investigated cognitive predictors in patients with confluent WML. METHODS: Among 100 patients with ischaemic stroke with confluent WML on MRI, the authors assessed executive function and global cognition by the Mattis Dementia Rating Scale--Initiation/Perseveration Subscale (MDRS I/P) and Mini-Mental State Examination (MMSE), respectively. All volumetric measures were corrected for intracranial volume. The authors investigated the association between basic demography, vascular risk factors, APOE status, WML volume, infarct measures (volume, number, location), microbleed number, atrophy measures (global, central, regional) and cognitive performance. The authors also performed Pittsburgh Compound B (PIB) imaging among seven cognitive impairedpatients with stroke. RESULTS: WML was no longer related to cognitive performance after adding atrophy into regression equations. Multivariate regression models showed that cortical grey matter volume independently accounted for performance on both the MDRS I/P (β=0.241, p=0.045) and MMSE (β=0.243, p=0.032). Models examining frontal subregions revealed that volumes of both left (β=0.424, p<0.001) and right (β=0.219, p=0.045) lateral frontal orbital gyri predicted MDRS I/P, whereas education (β=0.385, p<0.001) and left lateral frontal orbital gyrus (β=0.222, p=0.037) predicted MMSE. Volumes of WML and cognitively relevant brain regions were significantly associated. Seven patients with PIB imaging showed no uptake pattern typical of Alzheimer's disease, suggesting a predominantly vascular aetiology for the cognitive impairment and brain changes in these patients. CONCLUSIONS:Cognitive impairment in patients with confluent WML is mediated by global and frontal cortical atrophy.
Authors: María Carmona-Iragui; Mircea Balasa; Bessy Benejam; Daniel Alcolea; Susana Fernández; Laura Videla; Isabel Sala; María Belén Sánchez-Saudinós; Estrella Morenas-Rodriguez; Roser Ribosa-Nogué; Ignacio Illán-Gala; Sofía Gonzalez-Ortiz; Jordi Clarimón; Frederick Schmitt; David K Powell; Beatriz Bosch; Albert Lladó; Michael S Rafii; Elizabeth Head; José Luis Molinuevo; Rafael Blesa; Sebastián Videla; Alberto Lleó; Raquel Sánchez-Valle; Juan Fortea Journal: Alzheimers Dement Date: 2017-04-29 Impact factor: 21.566
Authors: H J Kim; B S Ye; C W Yoon; Y Noh; G H Kim; H Cho; S Jeon; J M Lee; J-H Kim; J-K Seong; C-H Kim; Y S Choe; K H Lee; S T Kim; J S Kim; S E Park; J-H Kim; J Chin; J Cho; C Kim; J H Lee; M W Weiner; D L Na; S W Seo Journal: Eur J Neurol Date: 2014-02-04 Impact factor: 6.089
Authors: Yunyun Xiong; Adrian Wong; Margherita Cavalieri; Reinhold Schmidt; Winnie W C Chu; Xinfeng Liu; Ka Sing Wong; Vincent Mok Journal: Neurotherapeutics Date: 2014-07 Impact factor: 7.620
Authors: Benjamin S Aribisala; Zoe Morris; Elizabeth Eadie; Avril Thomas; Alan Gow; Maria C Valdés Hernández; Natalie A Royle; Mark E Bastin; John Starr; Ian J Deary; Joanna M Wardlaw Journal: Hypertension Date: 2014-01-27 Impact factor: 10.190
Authors: Benjamin S Aribisala; Maria C Valdés Hernández; Natalie A Royle; Zoe Morris; Susana Muñoz Maniega; Mark E Bastin; Ian J Deary; Joanna M Wardlaw Journal: Eur Radiol Date: 2012-11-01 Impact factor: 5.315